The Company
The Company
Promore Pharma in Brief
Vision and Strategy
Market
Team
Board of Directors
Projects
Projects
Project Overview
Ensereptide – Prevention of Post-Surgical Adhesions and Scars
Ropocamptide – Healing of Chronic Wounds
Publications
Investors
Investors
Promore Pharma on Nasdaq First North Growth Market
Certified Adviser
The Share
Shareholders
Warrant Programs
Share capital development
Analysts
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe
Corporate Governance
Corporate Governance
Corporate Governance
General Meeting
General Meetings
Nomination Committee
Nomination Committees
The Board of Directors
Board of Directors
The Management
Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration
Media
Media
Press Releases
Imagebank
Promore Pharma in Media
Subscribe
Contact
Contact
Office
Investors
Media
Svenska
The Company
Promore Pharma in Brief
Vision and Strategy
Market
Team
Board of Directors
Projects
Project Overview
Ensereptide – Prevention of Scarring
Ropocamptide – Healing of Chronic Wounds
Publications
Investors
Promore Pharma on Nasdaq First North Growth Market
Certified Adviser
The Share
Shareholders
Warrant Programs
Share capital development
Analysts
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe
Corporate Governance
Corporate Governance
General Meeting
General Meetings
Nomination Committee
Nomination Committees
The Board of Directors
Board of Directors
The Management
Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration
Media
Press Releases
Imagebank
Promore Pharma in Media
Subscribe
Contact
Office
Investors
Media
Investors
Promore Pharma on Nasdaq First North Growth Market
Certified Adviser
The Share
Shareholders
Warrant Programs
Share capital development
Analysts
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe
Contact
Erik Magnusson
Chief Financial Officer (CFO)
+46 70 856 52 45
Financial Reports
All years
2022
2021
2020
2019
2018
2017
2016
2015
Select category
Annual Reports
Interim Reports
May 17, 2022
Promore Pharma — interim report January-March 2022
April 26, 2022
Promore Pharma’s Annual Report 2021 and AGM related Documents Published
February 16, 2022
Interim report January – December 2021
November 23, 2021
Interim report January – September 2021
August 24, 2021
Interim report January – June 2021
May 27, 2021
Interim report January – March 2021
May 6, 2021
Promore Pharma’s Annual Report 2020 and AGM related Documents Published
February 23, 2021
Year-end report 2020
November 24, 2020
Interim report January – September 2020
August 25, 2020
Promore Pharma AB (publ) Interim report January – June 2020
May 26, 2020
Promore Pharma AB (publ) Interim report January – March 2020
May 5, 2020
Promore Pharma’s Annual Report 2019 Published
February 18, 2020
Promore Pharma AB (publ) Year-end report 2019
November 22, 2019
Promore Pharma AB (publ) Interim report January – September 2019
August 28, 2019
Promore Pharma AB (publ) Interim report January – June 2019
May 21, 2019
Promore Pharma AB (publ) Interim report January – March 2019
April 30, 2019
Promore Pharma 2018 Annual report published
November 23, 2018
Promore Pharma AB (publ) Interim report January – September 2018
August 20, 2018
Interim report January – June 2018
May 16, 2018
Promore Pharma AB (publ) Interim report January – March 2018
April 25, 2018
Promore Pharma 2017 Annual report published
February 6, 2018
Year-end report 2017
November 21, 2017
Interim report January – September 2017
August 30, 2017
Interim report January – June 2017
May 19, 2017
Interim report January – March 2017
May 17, 2017
Promore Pharma AB – Annual Report July 2015 – December 2016
April 25, 2017
Pergamum AB – Annual Report July 2015 – December 2016
January 29, 2016
Pergamum AB – Annual Report 2014-07-01–2015-06-30
December 17, 2015
Lipopeptide AB – Annual Report 2014-07-01–2015-06-30
